| FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 | Sarah de Crescenzo | 06/15/20 | National |
| FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies | Bridget Silverman | 05/28/20 | National |
| FDA Authorizes “Emergency” Use of Gilead’s Remdesivir for Severe COVID-19 | Sarah de Crescenzo | 05/01/20 | National |
| Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More | Sarah de Crescenzo | 05/01/20 | National |
| Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
| Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
